| CAS ID: | 521079-87-8 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Monoclonal antibody |
| Natural Product: | No |
| Other Names: | TEFIBAZUMAB | AUREXIS | INH-H2002 |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT00198289 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 20, 2005 | Last Verified | March 29, 2013 |
| Sponsor | Bristol-Myers Squibb | ||
| PubChem: | 47207712 |
| ChEMBL: | CHEMBL2108055 |